ADAM17 and rheumatoid arthritis: Among these inflammation-related targets, ADAM17, TLR9, MIF, nuclear factor kappaB subunit 1 (NFKB1), NF-kappaB subunit (RELA), and Caspase 8 (CASP8) have been shown to promote the disease progression of RA.